Iterum Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ITRMF and buy or sell other stocks, ETFs, and their options commission-free!About ITRMF
Iterum Therapeutics Plc operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem. The company was founded by Corey N.
CEOCorey N. Fishman
CEOCorey N. Fishman
Employees—
Employees—
HeadquartersDublin, Dublin
HeadquartersDublin, Dublin
Founded2015
Founded2015
Employees—
Employees—
ITRMF Key Statistics
Market cap4.90K
Market cap4.90K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume8.81K
Average volume8.81K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.9073
52 Week high$0.9073
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
As of today, Iterum Therapeutics(ITRMF) shares are valued at $0.00. The company's market cap stands at 4.9K.
Iterum Therapeutics(ITRMF) stock opened on 2026-08-14 at —. The price climbed to — and dipped to —.
Iterum Therapeutics(ITRMF) shares are trading with a volume of 0, against a daily average of 8.81K.
During the past year, Iterum Therapeutics(ITRMF) stock moved between $0.00 at its lowest and $0.91 at its peak.
During the past year, Iterum Therapeutics(ITRMF) stock moved between $0.00 at its lowest and $0.91 at its peak.
People also own
Based on the portfolios of people who own ITRMF. This list is generated using Robinhood data, and it’s not a recommendation.